News - Royalty Pharma
网页2024年8月8日 — Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million Transactions NEW YORK, NY, May 28, 2024 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired an interest in Agios Pharmaceuticals’ royalty on Servier’s vorasidenib for $905 million in upfront cash contingent on U.S. Food ...
Royalty Pharma
网页Royalty Pharma is the world’s largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences. It partners with biotech and pharma companies, invests in research and development, and reports its financial results and news on its website.
Royalty Pharma Highlights Accomplishments and Provides …
网页2024年1月8日 — Royalty Pharma plc, a biopharmaceutical company, announced its 2023 performance and outlook at the J.P. Morgan Healthcare Conference. It expects Portfolio Receipts of $3,050 million in 2023 and...
Royalty Pharma plc (RPRX) Latest Stock News & Headlines
网页Get the latest news and updates on Royalty Pharma plc (RPRX), a biopharma company that buys and licenses royalties on pharmaceutical products. See press releases, earnings reports, analyst...
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
网页2024年5月9日 — Royalty Pharma plc, a biopharmaceutical royalty company, will pay $525 million to ImmuNext, Inc. for royalties and milestones on frexalimab, a potential blockbuster therapy for multiple...
Royalty Pharma Highlights Accomplishments and ... - Markets …
网页NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today provided an update on its business performance, including recent key accomplishments, and the full year 2023...
PureTech-Invented KarXT Receives U.S. Food and Drug …
网页1 天前 — PureTech’s monetization of equity holdings in Karuna, including gross proceeds from the BMS acquisition of Karuna, and a strategic royalty agreement with Royalty Pharma have enabled PureTech to ...
Royalty Pharma (RPRX) Stock Price, News & Analysis - MarketBeat
网页2 天之前 — Get the latest information on Royalty Pharma (RPRX), a biopharmaceutical royalty buyer and funder. See stock price, news, analysis, earnings, dividend, and more.
Royalty Pharma plc (RPRX) - Yahoo Finance
网页Get the latest stock price, news, quote and history of Royalty Pharma plc, a biotechnology company that buys and funds biopharmaceutical royalties. See its portfolio, earnings, dividends,...
Royalty Pharma Stock Price | RPRX Stock Quote, News, and …
网页The low in the last 52 weeks of Royalty Pharma stock was 25.23. According to the current price, Royalty Pharma is 109.79% away from the 52-week low. What was the 52-week …
跳至内容